EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fully Automated Serum LC-MS/MS Platform and Pediatric Reference Intervals for Organic Acids, Amino Acids, and Acylcarnitines in Children (Ages 0–6 Years): Toward Quantitative Diagnosis of Inborn Errors of Metabolism

Vollautomatisierte Serum-LC-MS/MS-Plattform und pädiatrische Referenzintervalle für organische Säuren, Aminosäuren und Acylcarnitine bei Kindern (0–6 Jahre): quantitative Diagnostik von Stoffwechselerkrankungen

Yasushi Ueyanagi iD, Daiki Setoyama, Tsuyoshi Nakanishi, Yuichi Mushimoto iD, Vlad Tocan, Hironori Kobayashi iD, Miki Matsui, Shinya Matsumoto, Akiyoshi Fujishima, Taeko Hotta, Ayumi Sakata iD, Yuya Kunisaki

Diagnostics · 19.03.2026 · 16 (6) · 911

DOI: 10.3390/diagnostics16060911 ↗

Auf einen Blick

Eine vollautomatisierte Serum-LC-MS/MS-Plattform wurde für 25 organische Säuren, 8 Aminosäuren und 21 Acylcarnitine entwickelt. In Proben von Kindern und IEM-Patient:innen lieferte sie quantitative Referenzintervalle und unterschied Krankheitsgruppen.

Fragestellung

Kann eine vollautomatisierte serumbasierte LC–MS/MS-Plattform ein integriertes quantitatives Metabolitprofil liefern und pädiatrische Referenzintervalle für die Diagnostik von IEM etablieren?

Methode

Entwicklung einer vollautomatisierten LC–MS/MS-Plattform mit CLAM-2030; Analyse von 296 Kindern ohne IEM zur Referenzintervall-Bildung und 89 IEM-Patient:innen zur klinischen Bewertung.

Ergebnisse

Die Methode zeigte r2 > 0,99, Nachweis-/Bestimmungsgrenzen nach Signal-Rausch-Verhältnis >3 und >10 sowie intra- und interassay Präzision <15 % CV für alle 54 Analyten. 21 Analyten erfüllten die Akzeptanzkriterien für ±20 % Genauigkeit.

Schlussfolgerung der Autor:innen

Die vollautomatisierte serumbasierte LC–MS/MS-Plattform bietet einen praktikablen, quantitativen Rahmen für integrierte Stoffwechselprofile mit pädiatrischen Referenzintervallen und unterstützt Diagnose und Verlaufskontrolle von IEM.

Kernaussagen

  • 54 Analyten wurden simultan quantifiziert.
  • 296 Kinder ohne IEM dienten zur Referenzintervall-Bildung.
  • In IEM-Seren lagen krankheitsspezifische Metabolite außerhalb der Referenzbereiche.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 19.03.2026. Verfasst von Yasushi Ueyanagi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Kyushu University Hospital, Fukuoka 812-8582, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Shimadzu corporation.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Conventional diagnosis of inborn errors of metabolism (IEMs) requires multiple specimen types—urine organic acids, plasma amino acids, and serum acylcarnitines—analyzed on distinct analytical platforms. This multi-assay approach is labor-intensive and limits timely clinical decision making. We aimed to develop a fully automated serum-based LC–MS/MS platform for integrated quantitative metabolite profiling and to establish pediatric reference intervals (RIs) to support diagnostic interpretation.

Methods

A fully automated LC–MS/MS system integrated with the CLAM-2030 automated pretreatment module was developed to enable simultaneous quantification of 25 organic acids, 8 amino acids, and 21 acylcarnitines. Analytical performance was assessed for linearity, limits of detection and quantification, precision and accuracy. Serum samples from 296 non-IEM children aged 0–6 years were analyzed to establish pediatric RIs using Box–Cox transformation and Gaussian modeling. Clinical utility was evaluated in sera from 89 patients diagnosed with IEM using z-score-based logistic regression models.

Results

The method demonstrated excellent performance, with linearity (r2 > 0.99) across calibration ranges, limits of detection and quantification defined by signal-to-noise ratios > 3 and >10, and intra- and inter-assay precision < 15% CV for all 54 analytes. Twenty-one analytes met the acceptance criterion of ±20% accuracy at all quality-control levels. Pediatric RIs provided a quantitative framework for interpreting the metabolic abnormalities. In IEM patients, disease-specific metabolites were consistently outside the established ranges, and z-score-based logistic regression models successfully distinguished major IEM categories, including organic acidemias and long-chain fatty acid oxidation disorders.

Conclusions

This fully automated, serum-based LC–MS/MS platform provides a clinically practical and quantitative framework for integrated metabolic profiling using pediatric RIs, supporting diagnosis and monitoring of IEMs in pediatric settings.

Schlagwörter

Stichwörter der Autor:innen

acylcarnitinesamino acidsinborn errors of metabolism (IEMs)liquid chromatography–tandem mass spectrometry (LC–MS/MS)organic acidspediatric reference intervals

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Kyushu University Hospital, Fukuoka 812-8582, Japan.
  • Shimadzu Corporation, Kyoto 604-8511, Japan.
  • Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
  • Clinical Laboratory Division, Shimane University Hospital, Izumo 693-8501, Japan.
  • Department of Pediatrics, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.
  • Department of Clinical Laboratory, International University of Health and Welfare Narita Hospital, Narita 286-8520, Japan.

ORCID-Profile: Yasushi Ueyanagi, Yuichi Mushimoto, Hironori Kobayashi, Ayumi Sakata

Förderung

  • Japan Society for the Promotion of Science
  • Shimadzu corporation

Zitieren

APA

Ueyanagi, Y., Setoyama, D., Nakanishi, T., Mushimoto, Y., Tocan, V., Kobayashi, H., Matsui, M., Matsumoto, S., Fujishima, A., Hotta, T., Sakata, A., & Kunisaki, Y. (2026). Fully Automated Serum LC-MS/MS Platform and Pediatric Reference Intervals for Organic Acids, Amino Acids, and Acylcarnitines in Children (Ages 0–6 Years): Toward Quantitative Diagnosis of Inborn Errors of Metabolism. Diagnostics, 16(6), 911. https://doi.org/10.3390/diagnostics16060911

Vancouver

Ueyanagi Y, Setoyama D, Nakanishi T, Mushimoto Y, Tocan V, Kobayashi H, et al. Fully Automated Serum LC-MS/MS Platform and Pediatric Reference Intervals for Organic Acids, Amino Acids, and Acylcarnitines in Children (Ages 0–6 Years): Toward Quantitative Diagnosis of Inborn Errors of Metabolism. Diagnostics. 2026;16(6):911. doi:10.3390/diagnostics16060911

BibTeX
@article{Ueyanagi2026,
  author = {Ueyanagi, Yasushi and Setoyama, Daiki and Nakanishi, Tsuyoshi and Mushimoto, Yuichi and Tocan, Vlad and Kobayashi, Hironori and Matsui, Miki and Matsumoto, Shinya and Fujishima, Akiyoshi and Hotta, Taeko and Sakata, Ayumi and Kunisaki, Yuya},
  title = {Fully Automated Serum LC-MS/MS Platform and Pediatric Reference Intervals for Organic Acids, Amino Acids, and Acylcarnitines in Children (Ages 0–6 Years): Toward Quantitative Diagnosis of Inborn Errors of Metabolism},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {911},
  doi = {10.3390/diagnostics16060911}
}
Kostenlos starten →